Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 181-190 of 290 for lung cancer

Edit search filters
  1. Maintenance Chemotherapy With Or Without Stereotactic Body Radiation Therapy In Treating Patients With Stage IV Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  2. Study Of TH-302 Or Placebo In Combination With Pemetrexed In Patients With Non-squamous Non-small Cell Lung Cancer

    Rochester, MN

  3. A Study Using Docetaxel With Or Without MLN1117 In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

    Rochester, MN

  4. A Study To Evaluate A New Anti-Cancer Vaccine For Patients With Non-Small Cell Lung Cancer, Given After Tumor Removal By Surgery

    Rochester, MN

  5. A Study Of Rociletinib (CO-1686) For Patients With A Mutant Form Of Non-Small Cell Lung Cancer.

    Scottsdale/Phoenix, AZ

  6. A Study Of Rovalpituzumab Tesirine As Maintenance Therapy Following First-Line Platinum-Based Chemotherapy In Participants With Extensive Stage Small Cell Lung Cancer (MERU)

    Rochester, MN

  7. Phase III Open Label First Line Therapy Study Of MEDI 4736 (Durvalumab) With Or Without Tremelimumab Versus SOC In Non Small-Cell Lung Cancer (NSCLC).

    Scottsdale/Phoenix, AZ

  8. Safety Study Of Nivolumab With Nab-Paclitaxel Plus Or Minus Gemcitabine In Pancreatic Cancer, Nab-Paclitaxel / Carboplatin In Stage IIIB/IV Non-Small Cell Lung Cancer Or Nab-Paclitaxel In Recurrent Metastatic Breast Cancer

    Scottsdale/Phoenix, AZ

  9. Phase II Trial Of Standard Chemotherapy +Various Proton Beam Therapy (PBT) Doses For Unresectable Stage 2/3 Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. Specialized Radiation Therapy And Chemotherapy In Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer